FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4381191076> ?p ?o ?g. }

• W4381191076 abstract "Highly concentrated antibody formulations are oftentimes required for subcutaneous, self-administered biologics. Here, we report the development of a unique formulation for our first-in-class FSH-blocking humanized antibody, MS-Hu6, which we propose to move to the clinic for osteoporosis, obesity, and Alzheimer’s disease. The studies were carried out using our Good Laboratory Practice (GLP) platform, compliant with the Code of Federal Regulations (Title 21, Part 58). We first used protein thermal shift, size exclusion chromatography, and dynamic light scattering to examine MS-Hu6 concentrations between 1 and 100 mg/mL. We found that thermal, monomeric, and colloidal stability of formulated MS-Hu6 was maintained at a concentration of 100 mg/mL. The addition of the antioxidant L-methionine and chelating agent disodium EDTA improved the formulation’s long-term colloidal and thermal stability. Thermal stability was further confirmed by Nano differential scanning calorimetry (DSC). Physiochemical properties of formulated MS-Hu6, including viscosity, turbidity, and clarity, confirmed with acceptable industry standards. That the structural integrity of MS-Hu6 in formulation was maintained was proven through Circular Dichroism (CD) and Fourier Transform Infrared (FTIR) Spectroscopy. Three rapid freeze–thaw cycles at –80 °C/25 °C or –80 °C/37 °C further revealed excellent thermal and colloidal stability. Furthermore, formulated MS-Hu6, particularly its Fab domain, displayed thermal and monomeric storage stability for more than 90 days at 4°C and 25°C. Finally, the unfolding temperature (T m ) for formulated MS-Hu6 increased by >4.80 °C upon binding to recombinant FSH, indicating highly specific ligand binding. Overall, we document the feasibility of developing a stable, manufacturable and transportable MS-Hu6 formulation at a ultra-high concentration at industry standards. The study should become a resource for developing biologic formulations in academic medical centers." @default.
• W4381191076 created "2023-06-20" @default.
• W4381191076 creator A5000185831 @default.
• W4381191076 creator A5001246578 @default.
• W4381191076 creator A5003290165 @default.
• W4381191076 creator A5016253785 @default.
• W4381191076 creator A5024813161 @default.
• W4381191076 creator A5025782791 @default.
• W4381191076 creator A5029736494 @default.
• W4381191076 creator A5035653029 @default.
• W4381191076 creator A5040443902 @default.
• W4381191076 creator A5043892922 @default.
• W4381191076 creator A5054310443 @default.
• W4381191076 creator A5062649230 @default.
• W4381191076 creator A5071909926 @default.
• W4381191076 creator A5087554418 @default.
• W4381191076 creator A5089822472 @default.
• W4381191076 creator A5090611203 @default.
• W4381191076 date "2023-06-19" @default.
• W4381191076 modified "2023-10-09" @default.
• W4381191076 title "Development and biophysical characterization of a humanized FSH–blocking monoclonal antibody therapeutic formulated at an ultra-high concentration" @default.
• W4381191076 cites W1181143902 @default.
• W4381191076 cites W1517079820 @default.
• W4381191076 cites W188537438 @default.
• W4381191076 cites W1967693680 @default.
• W4381191076 cites W1977437955 @default.
• W4381191076 cites W1987405744 @default.
• W4381191076 cites W1987741979 @default.
• W4381191076 cites W1993216667 @default.
• W4381191076 cites W1993823385 @default.
• W4381191076 cites W1999229038 @default.
• W4381191076 cites W2005255254 @default.
• W4381191076 cites W2012557883 @default.
• W4381191076 cites W2029992524 @default.
• W4381191076 cites W2033785641 @default.
• W4381191076 cites W2036879738 @default.
• W4381191076 cites W2060358529 @default.
• W4381191076 cites W2062476158 @default.
• W4381191076 cites W2063820727 @default.
• W4381191076 cites W2064543792 @default.
• W4381191076 cites W2071425823 @default.
• W4381191076 cites W2072513189 @default.
• W4381191076 cites W2073948759 @default.
• W4381191076 cites W2081787960 @default.
• W4381191076 cites W2103735104 @default.
• W4381191076 cites W2104571730 @default.
• W4381191076 cites W2107740219 @default.
• W4381191076 cites W2121959405 @default.
• W4381191076 cites W2140202728 @default.
• W4381191076 cites W2159840467 @default.
• W4381191076 cites W2229692518 @default.
• W4381191076 cites W2274171177 @default.
• W4381191076 cites W2326593475 @default.
• W4381191076 cites W2333779663 @default.
• W4381191076 cites W2343870312 @default.
• W4381191076 cites W2471997781 @default.
• W4381191076 cites W2512170617 @default.
• W4381191076 cites W2512181317 @default.
• W4381191076 cites W2515664994 @default.
• W4381191076 cites W2519414134 @default.
• W4381191076 cites W2587315616 @default.
• W4381191076 cites W2610034922 @default.
• W4381191076 cites W2618352462 @default.
• W4381191076 cites W2725756931 @default.
• W4381191076 cites W2792590877 @default.
• W4381191076 cites W2805668568 @default.
• W4381191076 cites W2884183896 @default.
• W4381191076 cites W2885499559 @default.
• W4381191076 cites W2894795071 @default.
• W4381191076 cites W2999958881 @default.
• W4381191076 cites W3034500342 @default.
• W4381191076 cites W3037273347 @default.
• W4381191076 cites W3046480764 @default.
• W4381191076 cites W3097838955 @default.
• W4381191076 cites W3131091842 @default.
• W4381191076 cites W3164032930 @default.
• W4381191076 cites W3173650784 @default.
• W4381191076 cites W3180814115 @default.
• W4381191076 cites W3214877553 @default.
• W4381191076 cites W3217330772 @default.
• W4381191076 cites W4214944386 @default.
• W4381191076 cites W4220851910 @default.
• W4381191076 cites W4238520503 @default.
• W4381191076 cites W4297855471 @default.
• W4381191076 cites W4304689386 @default.
• W4381191076 cites W4315620353 @default.
• W4381191076 cites W4317481328 @default.
• W4381191076 doi "https://doi.org/10.7554/elife.88898" @default.
• W4381191076 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37334968" @default.
• W4381191076 hasPublicationYear "2023" @default.
• W4381191076 type Work @default.
• W4381191076 citedByCount "1" @default.
• W4381191076 countsByYear W43811910762023 @default.
• W4381191076 crossrefType "journal-article" @default.
• W4381191076 hasAuthorship W4381191076A5000185831 @default.
• W4381191076 hasAuthorship W4381191076A5001246578 @default.
• W4381191076 hasAuthorship W4381191076A5003290165 @default.
• W4381191076 hasAuthorship W4381191076A5016253785 @default.
• W4381191076 hasAuthorship W4381191076A5024813161 @default.
• W4381191076 hasAuthorship W4381191076A5025782791 @default.

• next